Literature DB >> 21771303

Bilateral optic neuritis in a 26-year-old man with common variable immunodeficiency: a case report.

Angel P Sempere1, Ml Tahoces, Susana Palao-Duarte, Alfonso Garcia-Perez.   

Abstract

INTRODUCTION: Common variable immunodeficiency encompasses a group of heterogeneous conditions linked by a lack of immunoglobulin production and primary antibody failure. Although primary immunodeficiencies are typically characterized by recurrent infections, autoimmune manifestations have increasingly been recognized. Neurological complications are extremely rare and to the best of our knowledge optic neuritis has not been described previously. We report the case of a patient with common variable immunodeficiency who developed loss of vision secondary to bilateral optic neuritis. CASE
PRESENTATION: A 26-year-old Caucasian man with a diagnosis of common variable immunodeficiency presented to our facility with loss of vision secondary to bilateral optic neuritis. Results of a thorough study for infectious, neoplastic and autoimmune diseases were negative. Our patient was treated with intravenous methylprednisolone with almost complete improvement and he remained asymptomatic at a 12-month follow-up.
CONCLUSIONS: Bilateral optic neuritis should be added to the list of autoimmune disorders related to common variable immunodeficiency. If a patient with common variable immunodeficiency experiences loss of vision, the possibility of bilateral optic neuritis should be considered as rapid initiation of high-dose corticosteroids may improve visual recovery.

Entities:  

Year:  2011        PMID: 21771303      PMCID: PMC3150318          DOI: 10.1186/1752-1947-5-319

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  6 in total

1.  Uveitis in a patient with common variable immunodeficiency.

Authors:  R Gray; J Vodden; M Gompels
Journal:  Eye (Lond)       Date:  2003-01       Impact factor: 3.775

Review 2.  EFNS guidelines on diagnosis and management of neuromyelitis optica.

Authors:  J Sellner; M Boggild; M Clanet; R Q Hintzen; Z Illes; X Montalban; R A Du Pasquier; C H Polman; P S Sorensen; B Hemmer
Journal:  Eur J Neurol       Date:  2010-06-07       Impact factor: 6.089

3.  Clinical profile of simultaneous bilateral optic neuritis in adults.

Authors:  J de la Cruz; M J Kupersmith
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

4.  Common variable immunodeficiency-associated myelitis: report of treatment with infliximab.

Authors:  N Kumar; J B Hagan; R S Abraham; A J Aksamit
Journal:  J Neurol       Date:  2008-07-21       Impact factor: 4.849

5.  Retinal vasculitis occurring with common variable immunodeficiency syndrome.

Authors:  J C van Meurs; S Lightman; P W de Waard; G S Baarsma; L W van Suijlekom-Smit; J P van de Merwe; R de Groot
Journal:  Am J Ophthalmol       Date:  2000-02       Impact factor: 5.258

Review 6.  Autoimmune manifestations in primary immune deficiencies.

Authors:  Guillaume Bussone; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2008-11-24       Impact factor: 9.754

  6 in total
  4 in total

1.  Incidental frontoparietal parasagittal meningioma in a patient with acute bilateral optic neuritis.

Authors:  Su-Ho Lim; Sung-Hyuk Moon; Myung-Mi Kim
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

2.  Neurologic Complications of Common Variable Immunodeficiency.

Authors:  Jenna Thuc-Uyen Nguyen; Ari Green; Michael R Wilson; Joseph L DeRisi; Katherine Gundling
Journal:  J Clin Immunol       Date:  2016-10-04       Impact factor: 8.317

Review 3.  Ocular involvement in primary immunodeficiency diseases.

Authors:  Sima Hosseinverdi; Hassan Hashemi; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2013-11-30       Impact factor: 8.542

4.  Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.

Authors:  Jake E Cowen; James Stevenson; Madhusudan Paravasthu; James Darroch; Anu Jacob; Salaheddin Tueger; John R Gosney; Anneliese Simons; Lisa G Spencer; Eoin P Judge
Journal:  BMC Pulm Med       Date:  2020-07-31       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.